Article thumbnail
Location of Repository

Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring

By K. E. Stephan, K. J. Friston and C. D. Frith


Over the last 2 decades, a large number of neurophysiological and neuroimaging studies of patients with schizophrenia have furnished in vivo evidence for dysconnectivity, ie, abnormal functional integration of brain processes. While the evidence for dysconnectivity in schizophrenia is strong, its etiology, pathophysiological mechanisms, and significance for clinical symptoms are unclear. First, dysconnectivity could result from aberrant wiring of connections during development, from aberrant synaptic plasticity, or from both. Second, it is not clear how schizophrenic symptoms can be understood mechanistically as a consequence of dysconnectivity. Third, if dysconnectivity is the primary pathophysiology, and not just an epiphenomenon, then it should provide a mechanistic explanation for known empirical facts about schizophrenia. This article addresses these 3 issues in the framework of the dysconnection hypothesis. This theory postulates that the core pathology in schizophrenia resides in aberrant N-methyl-D-aspartate receptor (NMDAR)–mediated synaptic plasticity due to abnormal regulation of NMDARs by neuromodulatory transmitters like dopamine, serotonin, or acetylcholine. We argue that this neurobiological mechanism can explain failures of self-monitoring, leading to a mechanistic explanation for first-rank symptoms as pathognomonic features of schizophrenia, and may provide a basis for future diagnostic classifications with physiologically defined patient subgroups. Finally, we test the explanatory power of our theory against a list of empirical facts about schizophrenia

Topics: Dysconnectivity, corollary discharge, psychosis, hallucinations, delusions, NMDA, dopamine, acetylcholine, serotonin, effective connectivity, dynamic causal modeling, DCM, predictive coding
Year: 2009
OAI identifier:
Provided by: UCL Discovery

Suggested articles


  1. 17ss-estradiol modifies stress-induced and age-related changes in hippocampal synaptic plasticity.
  2. (1906). 4. Bleuler E. Dementia Praecox or the Group of Schizophrenias.
  3. (1992). A comparison of endocrine reactions to different types of acute stressors in rural and urban black populations. Stress Med.
  4. A disturbance of nonlinear interdependence in scalp EEG of subjects with first episode schizophrenia.
  5. A neural mass model of spectral responses in electrophysiology.
  6. (1997). A neural substrate of prediction and reward.
  7. (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci.
  8. A noncanonical release of GABA and glutamate modulates neuronal migration.
  9. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control).
  10. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler.
  11. A review of diffusion tensor imaging studies in schizophrenia.
  12. A theory of cortical responses.
  13. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory.
  14. Activity-dependent cleavage of brain glutamic acid decarboxylase 65 by calpain.
  15. (2001). Activity-dependent expression of GAD67 in the granule cells of the rat hippocampus. Brain Res.
  16. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med.
  17. Androgen modulation of hippocampal synaptic plasticity.
  18. Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex.
  19. (2004). Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry.
  20. Bayesian estimation of synaptic physiology from the spectral responses of neural masses.
  21. (2005). Blinking suppresses the neural response to unchanging retinal stimulation. Curr Biol.
  22. (1998). Brain activations in schizophrenia during a graded memory task studied with functional neuroimaging. Arch Gen Psychiatry.
  23. Brain interactions in chronic schizophrenics under resting and activation conditions. Schizophr Res.
  24. Brain mechanisms in normal and dyslexic readers.
  25. BreierA,SuTP,SaundersR,etal.Schizophreniaisassociated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
  26. (2006). Cellular basis of reduced cortical reelin expression in schizophrenia.
  27. Central control of dendritic spikes shapes the responses of Purkinje-like cells through spike timing-dependent synaptic plasticity.
  28. Central versus peripheral determinants of patterned spike activity in rat vibrissa cortex during whisking.
  29. Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study.
  30. Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors.
  31. (1994). Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects.
  32. (1999). Clozapine: dopamine D1 receptor agonism in the prefrontal cortex as the code to decipher a Rosetta stone of antipsychotic drugs. Pharmacol Toxicol.
  33. Cocaine enhances NMDA receptor-mediated currents in ventral tegmental area cells via dopamine D5 receptor-dependent redistribution of NMDA receptors.
  34. Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning.
  35. communication in schizophrenia.
  36. ConsensusCognitiveBattery,part1:testselection,reliability, and validity.
  37. Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia. Behav Brain Sci.
  38. (1987). Convergence of electrotonic club endings, GABA- and serotoninergic terminals on second order neurons of the electrosensory pathway in mormyrid fish, Gnathonemus petersii and Brienomyrus niger (Teleostei). Cell Tissue Res.
  39. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci.
  40. (2006). D-serine signalling in the brain: friend and foe. Trends Neurosci.
  41. (2000). Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry.
  42. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry.
  43. Dendrite growth increased by visual activity requires NMDA receptor and Rho GTPases.
  44. (1999). Dendritic spine changes associated with hippocampal long-term synaptic plasticity.
  45. Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.
  46. (1994). Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull.
  47. (1999). DierksT,LindenDE,JandlM,etal.ActivationofHeschl’sgyrus during auditory hallucinations.
  48. Diffusion tensor imaging in schizophrenia.
  49. (1993). Dimensional complexity of EEG brain mechanisms in untreated schizophrenia. Biol Psychiatry.
  50. (2004). Discrete synaptic states define a major mechanism of synapse plasticity. Trends Neurosci.
  51. (1996). Disordered functional connectivity in schizophrenia. Psychol Med.
  52. Disorders of agency in schizophrenia correlate with an inability to compensate for the sensory consequences of actions.
  53. Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions.
  54. (2008). Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull.
  55. (2008). Do patients with schizophrenia exhibit aberrant salience? Psychol Med.
  56. (2007). Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action. Pharmacopsychiatry.
  57. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
  58. Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity.
  59. dopamine release in the nucleus accumbens.
  60. Dopamine-dependent prediction errors underpin rewardseeking behaviour in humans.
  61. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.
  62. Dynamic causal modeling.
  63. Dynamic causal modelling of evoked responses in EEG
  64. Dynamic causal models of neural system dynamics: current state and future extensions.
  65. (1992). Dysconnectivity in Schizophrenia a t U C L L i b r a r y S e r v i c e s o n A u g u s t , h t t p : / / s c h i z o p h r e n i a b u l l e t i n . o x f o r d j o u r n a l s . o r g D o w n l o a d e d f r o m
  66. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia.
  67. (2008). Dysfunctional neural plasticity in patients with schizophrenia. Arch Gen Psychiatry.
  68. (1991). EEG coherence of prefrontal areas in normal and schizophrenic males during perceptual activation.
  69. (2001). Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Cogn Brain Res.
  70. Effect of nicotine on hippocampal nicotinic acetylcholine alpha7 receptorandNMDAreceptorsubunits2Aand2Bexpressionin young and old rats.
  71. Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats.
  72. Effects of repeated prenatal glucocorticoid exposure on long-term potentiation in the juvenile guinea-pig hippocampus.
  73. (1978). Efference copy and corollary discharge: implications for thinking and its disorders. Schizophr Bull.
  74. (2001). Electrical activity and development of neural circuits. Nat Neurosci.
  75. (2005). Elevated cortisol levels and increased rates of diabetes and mood symptoms in Soviet Union-born Jewish immigrants to Germany. Mol Psychiatry.
  76. (2006). Endocannabinoidmediated synaptic plasticity in the CNS. Annu Rev Neurosci.
  77. (1997). Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor–mediated synaptic input: correlation with dendritic spine density. J Neurosci.
  78. Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors.
  79. (1993). Exp Ther.
  80. (2004). FarrerC,FranckN,FrithCD,etal.Neuralcorrelatesofaction attribution in schizophrenia. Psychiatry Res.
  81. (1997). FrangouS,MurrayRM.Thedysplasticnethypothesis:anintegrationofdevelopmentalanddysconnectivity theories of schizophrenia. Schizophr Res.
  82. (2007). From inverse problems in mathematical physiology to quantitative differential diagnoses. PLoS Comput Biol.
  83. Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. Focal dysfunction and distributed disconnectivity reappraised.
  84. Functional coupling between the prefrontal cortex and dopamine neurons in the ventral tegmental area.
  85. (1996). Functional topography: multidimensional scaling and functional connectivity in the brain. Cereb Cortex.
  86. Gamma synchrony’’ in first-episode schizophrenia: a disorder of temporal connectivity?
  87. (1978). Genetic transmission of schizophrenia. Annu Rev Med.
  88. (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry.
  89. (2005). Hallucinations and perceptual inference. Behav Brain Sci.
  90. Hierarchical organization of human cortical networks in health and schizophrenia.
  91. HoneyGD,CorlettPR,AbsalomAR,etal.Individualdifferencesinpsychoticeffectsofketaminearepredictedbybrainfunction measured under placebo.
  92. HuaJY,SmithSJ.Neuralactivityandthedynamicsofcentral nervous system development.
  93. impairment in neuroleptic-free schizophrenics.
  94. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia.
  95. (2008). in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci.
  96. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci
  97. (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry.
  98. (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
  99. Induction of long-term depression is associated with decreased dendritic length and spine density in layers III and V of sensorimotor neocortex.
  100. Inhibition of NMDA receptormediated synaptic transmission in the rat dentate gyrus in vitro by IL-1 beta.
  101. (1995). Int Clin Psychopharmacol.
  102. (2007). Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/ calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol Pharmacol.
  103. (1998). Is clozapine an (partial) agonist at both dopamine D1 and D2 receptors? Psychopharmacology (Berl).
  104. (2005). Ka ¨hko ¨nen S, Ma ¨kinen V, Ja ¨a ¨skela ¨inen
  105. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry.
  106. (1999). Ketamine-induced NMDA receptorhypofunctionas amodel of memory impairment and psychosis.
  107. (1950). Klinische Psychopathologie.
  108. Learning rules for spike timing-dependent plasticity depend on dendritic synapse location.
  109. (1999). Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons.
  110. (2004). Long-term potentiation induces expanded movement representations and dendritic hypertrophy in layer V of rat sensorimotor neocortex. Cereb Cortex.
  111. Long-term potentiation of excitatory inputs to brain reward areas by nicotine.
  112. Long-term potentiation of exogenous glutamate responses at single dendritic spines.
  113. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther. 2005;27(suppl A):S16–S24.
  114. Mechanisms by which dopamine receptors may influence synaptic plasticity.
  115. Mechanisms of usedependent plasticity in the human motor cortex.
  116. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet.
  117. (2005). Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res.
  118. (2000). Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol Psychiatry.
  119. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
  120. (2004). N-methyl-Daspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking. Prog Neuropsychopharmacol Biol Psychiatry.
  121. (1978). Na ¨a ¨ta ¨nen R, Gaillard AWK, Ma ¨ntysalo S. Early selectiveattention effect on evoked potential reinterpreted. Acta Psychol.
  122. (2005). Neonatal NMDA receptor blockade disturbs neuronal migration in rat somatosensory cortex in vivo. Cereb Cortex.
  123. Neural basis of the spontaneous optokinetic response produced by visual inversion.
  124. Neural synchrony indexes disordered perception and cognition in schizophrenia.
  125. Neuromodulators control the polarity of spike-timing-dependent synaptic plasticity.
  126. Neurotrophins and cytokines in neuronal plasticity. Novartis Found Symp.
  127. (2002). Nicotine exposure during a postnatal critical period alters NR2A and NR2B mRNA expression in rat auditory forebrain. Brain Res Dev Brain Res.
  128. Nicotinic modulation of human auditory sensory memory: evidence from mismatch negativity potentials.
  129. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.
  130. (2007). NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci.
  131. (2003). NR2B downregulation in a forebrain region required for avian vocal learning is not sufficient to close the sensitive period for song learning. Neurobiol Learn Mem.
  132. OadesRD,SchepkerR.Serumgonadalsteroidsinyoungschizophrenic patients.
  133. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia.
  134. Pathophysiologically based treatment interventions in
  135. Phencyclidine-induced psychosis.
  136. Physiol A Neuroethol Sens Neural Behav Physiol.
  137. (1999). Predictive coding in the visual cortex: a functional interpretation of some extra-classical receptivefield effects. Nat Neurosci.
  138. (2007). Predictive coding: an account of the mirror neuron system. Cogn Process.
  139. Prenatal developmental disturbances in the limbic allocortex in schizophrenics.
  140. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.
  141. (1999). Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area.
  142. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.
  143. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.
  144. (2002). Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry.
  145. (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia.
  146. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations.
  147. Reduced gamma-band coherence to distorted feedback during speech when what you say is not what you hear.
  148. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning.
  149. Reelin modulates NMDA receptor activity in cortical neurons.
  150. (1998). regional, and local measures of complexity of multichannel electroencephalography in acute, neuroleptic-naive, first-break schizophrenics. Biol Psychiatry.
  151. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex.
  152. (2006). Repetition effects to sounds: evidence for predictive coding in the auditory system. Trends Cogn Sci.
  153. Requirement of an allosteric kinetics of NMDA receptors for spike timing-dependent plasticity.
  154. Requirement of dendritic calcium spikes for induction of spike-timingdependent synaptic plasticity.
  155. Reversible associative depression and nonassociative potentiation at a parallel fiber synapse.
  156. (2004). Rı ´o J. NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment. Psychopharmacology (Berl).
  157. (1996). Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci USA.
  158. Saccadic suppression by corollary discharge in the locust.
  159. Salazar-ColochoP,DelRı ´oJ,FrechillaD.Serotonin5-hT1A receptor activation prevents phosphorylation of NMDA receptor NR1 subunit in cerebral ischemia.
  160. (1996). Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA.
  161. (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry.
  162. (2005). Schizophrenia genes, gene expression and neuropathology: on the matter of their convergence. Mol Psychiatry.
  163. Schizophrenia—a disorder of the corollary discharge systems that integrate the motor systems of thought with the sensory systems of consciousness.
  164. (1995). Schizophrenia: a disconnection syndrome? Clin Neurosci.
  165. Selective D2 receptor actions on the functional circuitry of working memory.
  166. (2002). Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav.
  167. Sensory coding and corollary discharge effects in mormyrid electric fish.
  168. Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism.
  169. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons.
  170. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
  171. Sjo ¨stro ¨m PJ, Turrigiano GG, Nelson SB. Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors.
  172. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry.
  173. Spike timing-dependent plasticity: a learning rule for dendritic integration in rat CA1 pyramidal neurons.
  174. Spike timing-dependent serotonergic neuromodulation of synaptic strength intrinsic to a central pattern generator circuit.
  175. StephanKE,KasperL,HarrisonLM,etal.Nonlineardynamic causal models for fMRI.
  176. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms.
  177. (2000). Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry.
  178. (2008). Substantia nigra/ ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry.
  179. (2001). Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat Neurosci.
  180. (2006). Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry.
  181. (1997). Synaptic plasticity in a cerebellum-like structure depends on temporal order.
  182. (2003). Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia. Brain Res Rev.
  183. Targeting prefrontal cortical dopamine D1 and N-methyl-D-aspartate receptor interactions in schizophrenia treatment.
  184. Testosterone decreases CA1 plasticity in vivo in gonadectomized male rats.
  185. (2007). The amphetamineinduced sensitized state as a model of schizophrenia. ProgNeuropsychopharmacol Biol Psychiatry.
  186. The cellular basis of a corollary discharge.
  187. (1992). The Cognitive Neuropsychology of Schizophrenia.
  188. (1998). The disconnection hypothesis. Schizophr Res.
  189. The effect of varying stimulus intensity on NMDA receptor activity in cat visual cortex.
  190. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
  191. The formation of abnormal associations in schizophrenia: neural and behavioral evidence.
  192. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.
  193. (1992). The left medial temporal region and schizophrenia. A PET study.
  194. (2007). The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch Neurol.
  195. (1998). The NMDA antagonist model for schizophrenia: promise and pitfalls.
  196. (2006). The NMDA/D1 receptor complex as a new target in drug development. Curr Top Med Chem.
  197. (2000). The perception of self-produced sensory stimuli in patients with auditory hallucinations and passivity experiences: evidence for a breakdown in self-monitoring. Psychol Med.
  198. (1987). The positive and negative symptoms of schizophrenia reflect impairments in the perception and initiation of action. Psychol Med.
  199. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro.
  200. The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesis.
  201. (1996). Theoretical neurobiology and schizophrenia. Br Med Bull.
  202. Towards a neuropsychology of schizophrenia.
  203. (2005). Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry.
  204. (2007). Understanding cannabinoid psychoactivity with mouse genetic models. PLoS Biol.
  205. Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine selfadministration.
  206. Value-dependent selection in the brain: simulation in a synthetic neural model.
  207. What the brain stem tells the frontal cortex. I. Oculomotor signals sent from superior colliculus to frontal eye field via mediodorsal thalamus.
  208. What the brain stem tells the frontal cortex. II. Role of the SC-MD-FEF pathway in corollary discharge.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.